Medical devices, healthcare technology and the business of care
510(k) clearance · K254212

NC PTA Balloon Dilatation Catheter

Kossel Medtech (Suzhou) Co., Ltd. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK254212

What did the FDA decide?

On September 16, 2026, FDA recorded a substantially equivalent (SESE) decision for the NC PTA Balloon Dilatation Catheter submitted by Kossel Medtech (Suzhou) Co., Ltd. under K254212, product code LIT, cardiovascular specialty. The document states the device is indicated for percutaneous transluminal angioplasty of the peripheral vasculature. The catheter is described as a two-lumen design, with one lumen used for balloon inflation and deflation.

The decision letter states that differences between the subject device and the predicate and reference devices do not raise new questions of safety or effectiveness. The excerpts also reference the Maxi Diameter Balloon PTA Dilatation Catheter and the Atlas Gold PTA Dilatation Catheter as comparator devices. The source does not provide the full indications text, the complete predicate list, or the basis for the equivalence finding, so those details remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254212
Regulatory pathway
510(k) premarket notification
Product code
LIT
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Angioplasty, Peripheral, Transluminal.

Product code
LIT
FDA device class
2

FDA decision timeline

  1. K254212 received

    Application receipt date recorded by FDA.

  2. K254212 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LIT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kossel Medtech (Suzhou) Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Suzhou New District

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records